You should change up the area where youre injecting your medications regularly, so you avoid irritating the injection sites with too much frequent usage
If your calculation shows 7.5 units, some people round down to 7 units to be conservative, while others round up to 8 units to avoid underdosing
As the active ingredient in Ozempic and Wegovy , it works by targeting the brains appetite-control center , regulating blood sugar and insulin , and slowing digestion to naturally reduce hunger and food intake
Semaglutide Quick Facts: Drug Class: GLP-1 receptor agonist Brand Names: Ozempic (diabetes), Wegovy (weight loss), Rybelsus (oral) FDA Approval: Ozempic approved 2017, Wegovy approved 2021 Manufacturer: Novo Nordisk Dosing: Once weekly injection, starting at 0.25 mg, maximum 2.4 mg Clinical Trial Name: STEP trials (Semaglutide Treatment Effect in People with obesity) Average Weight Loss: 10-15% of body weight over 68 weeks Tirzepatide Quick Facts: Drug Class: Dual GIP/GLP-1 receptor agonist Brand Names: Mounjaro (diabetes), Zepbound (weight loss) FDA Approval: Mounjaro approved 2022, Zepbound approved 2023 Manufacturer: Eli Lilly Dosing: Once weekly injection, starting at 2.5 mg, maximum 15 mg Clinical Trial Name: SURMOUNT trials (Study to evaluate tirzepatide in obesity or overweight) Average Weight Loss: 15-22% of body weight over 72 weeks Primary Difference: The main distinction is that semaglutide activates only GLP-1 receptors, while tirzepatide activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors
The rationale extends beyond simple formulation chemistry into the realm of NAD+ precursor biology, mitochondrial function, and adipose tissue metabolism
